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A Mendelian randomization study 
of testosterone and cognition in 
men
Jie V. Zhao1, Tai Hing Lam1, Chaoqiang Jiang2, Stacey S Cherny3, Bin Liu2, Kar Keung Cheng4, 
Weisen Zhang2, Gabriel M Leung1 & C Mary Schooling1,5
Testosterone replacement for older men is increasingly common, with some observations suggesting 
a protective effect on cognitive function. We examined the association of endogenous testosterone 
with cognitive function among older men in a Mendelian randomization study using a separate-sample 
instrumental variable (SSIV) analysis estimator to minimize confounding and reverse causality. A 
genetic score predicting testosterone was developed in 289 young Chinese men from Hong Kong, 
based on selected testosterone-related single nucleotide polymorphisms (rs10046, rs1008805 and 
rs1256031). The association of genetically predicted testosterone with delayed 10-word recall score 
and Mini-Mental State Examination (MMSE) score was assessed at baseline and follow-up using 
generalized estimating equation among 4,212 older Chinese men from the Guangzhou Biobank Cohort 
Study. Predicted testosterone was not associated with delayed 10-word recall score (−0.02 per nmol/L 
testosterone, 95% confidence interval (CI) −0.06–0.02) or MMSE score (0.06, 95% CI −0.002–0.12). 
These estimates were similar after additional adjustment for age, education, smoking, use of alcohol, 
body mass index and the Framingham score. Our findings do not corroborate observed protective 
effects of testosterone on cognitive function among older men.
Testosterone has attracted great interest as a therapy for older men in the last few years, especially in North 
America1. Animal experiments suggest testosterone improves spatial cognition in male rats2,3. The evidence in 
humans is inconsistent and unclear (Table 1). Some observational studies suggest testosterone is associated with 
better verbal memory or higher Mini-Mental State Examination (MMSE) score4,5, although only among older 
men4 or only for MMSE at baseline5; whilst others suggest the association of testosterone with cognitive function 
is null6 or negative7. Observational studies are open to residual confounding and reverse causality8. Evidence from 
randomized controlled trials (RCTs) of testosterone administration in older men is also inconsistent, suggesting 
no effect9,10, or potential benefits for verbal and spatial memory11 or MMSE12. In contrast, another RCT showed a 
decrease in verbal memory13, suggesting potential harm for cognitive function. Similarly, evidence from a recent 
meta-analysis of interventional studies also showed unclear effects of androgen deprivation therapy on cognitive 
function14. As such, the role of testosterone in cognition remains unclear, and improved cognition remains a 
potential benefit15.
Using naturally occurring testosterone-related genetic variants in a Mendelian randomization (MR) study 
design provides a means of examining the causal effects of testosterone on cognitive function without any inter-
ventions. Genetic variants determined at conception, resulting in life-long differences in exposures, are unlikely 
to be associated with socioeconomic position or other confounders. Testosterone falls with age and ill-health16,17, 
and cognitive impairment has a long pre-clinical course, thus lifetime testosterone exposure may be more relevant 
than contemporaneous exposure in older men, however obtaining biomaterials indicating lifetime testosterone 
exposure is not currently feasible. An MR study with a separate-sample instrumental variable (SSIV) analysis 
using genetic instruments enables examination of the association of endogenous testosterone, unaffected by aging 
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or ill-health, with cognitive function. Here, we used a separate-sample MR study design to assess the effect of 
endogenous peak testosterone on cognitive function in older men.
Results
Genetically predicted log testosterone was calculated as − 0.07 × rs1008805 + 0.07 × rs10046 −0.07 × rs1256031 + 
3.0, as previously18. The proportion of the variance in log testosterone explained by genetically predicted log 
testosterone was 4.1%, which is typical for MR studies19. An instrument explaining all the variance in serum 
testosterone would be invalid because it would be equivalent to serum testosterone, and so would not provide an 
unconfounded estimate. The F-statistic was 13.3, suggesting a reliable instrument.
Among the 8,450 men in all 3 phases of the Guangzhou Biobank Cohort Study (GBCS), DNA was extracted 
from blood samples and used for single nucleotide polymorphism (SNP) testing for 4,262 men, with availability 
depending on phase of recruitment and other logistical concerns, but not on genetic profile or cognitive function. 
Men with SNPs tested had higher baseline delayed 10-word recall score (mean difference 0.22, 95% confidence 
interval (CI) 0.14–0.30) than men without SNP testing, but were not different in baseline MMSE (mean dif-
ference − 0.17, 95% CI − 0.37–0.03), assessed from linear regression adjusted for age; small differences could 
occur by chance. Among these 4,262 men, 4,212 (98.8%) had complete information on the three SNPs. None 
Main references
Study design Exposure
Cognitive 
function Author, year
Sample 
size 
(men)
Mean age 
(years) Main findings
Observational studies
Serum testosterone ↑ in older people Muller, 2005
4 400 60.2
Curvilinear 
association with 
verbal memory, 
which disappears 
in age subgroups; 
only associated 
with better verbal 
memory in the 
oldest age group, 
no association in 
other age groups. 
No association with 
MMSE.
↑ ↔ Hogervorst, 20105 257 74.4
Optimal TT 
associated with 
better MMSE 
at baseline, no 
association with 
MMSE change or 
verbal memory
↔ LeBlanc, 201063 1602 NA
No association with 
modified mental 
state examination 
(3MS), which 
includes MMSE
↓ Martin, 20077 1195 54.3
Associated with 
worse verbal 
memory
RCTs
Testosterone administration ↔ Haren, 20059 76 68.5 No effect on MMSE
↔ Sih, 199710 15 68 No effect on verbal memory
↓ ↔ Maki, 200713 15 73.9
Decreased 
short-delay verbal 
memory; no effect 
on composite verbal 
memory
↑ Cherrier, 200511 32 76 Increased verbal and spatial memory
↑ Wahjoepramono, 201512 44 NA Increased MMSE
Meta-analysis of 
interventional studies
Androgen deprivation 
therapy (ADT) ↓ ↔ McGinty, 2014
14 417 63.2–71.0
Prostate cancer 
patients receiving 
ADT had worse 
performance on 
visuomotor tasks 
compared to 
noncancer control 
groups. No effect 
on other cognitive 
domains.
Table 1.  Main findings from epidemiological studies on testosterone and cognitive function in men. TT, 
total testosterone; MMSE, Mini-Mental State Examination; ADT, Androgen deprivation therapy; NA, not 
available currently. ↑ means a positive association with or an increase in cognitive function; ↓ means a negative 
association with or a decrease in cognitive function; ↔ means no association or no effect.
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of these SNPs deviated from Hardy-Weinburg equilibrium in GBCS. Among the 4,212 men, 4,160 had 10-word 
recall from baseline or follow-up (3,330 from both baseline and follow-up, 712 from baseline only and 118 from 
follow-up only). 4,122 had MMSE score from baseline or follow-up (891 from both baseline and follow-up, 628 
from baseline only, and 2,603 from follow-up only). As would be expected, genetically predicted testosterone was 
not associated with age, education, smoking status or use of alcohol (Table 2).
Table 3 shows genetically predicted testosterone was not associated with delayed 10-word recall score. The 
estimates were close to the null. The estimate for the association of genetically predicted testosterone with MMSE 
score was positive but the 95% CI included the null. The estimates remained unchanged after adjustment for 
covariates (Models 2–5) and after excluding men selected for another cognition-related project (Model 6)20, 
although in model 3 genetically predicted testosterone was associated with higher MMSE score. The association 
of genetically predicted testosterone with delayed 10-word recall and MMSE did not vary with age (p-values for 
interaction 0.13 and 0.11).
Discussion
Using an MR study design to minimize confounding and reverse causality, we found no clear indication that 
endogenous testosterone was associated with improved cognitive function in older Chinese men, although we 
cannot rule out a small positive effect on MMSE. Our novel study provides limited support for any protective 
effects of endogenous testosterone on cognitive function.
The strengths of our study include using an MR study design with two separate samples (SSIV) to achieve an 
unbiased estimate. Simulations have shown MR with two separate samples is preferable to using the same sample 
for assessing the relations of the instrument with the exposure and the instrument with the outcome21. SSIV is 
useful and cost-efficient when the phenotype of interest was either not measured or was measured with substan-
tial error in the sample with the outcome22,23. The MR design makes it feasible to use testosterone in early adult-
hood as a marker of lifetime exposure, when it is infeasible to obtain lifetime testosterone for older men. Thus, we 
avoid the imprecision in MR estimates that could arise from assessing the genetic association with testosterone in 
older age, when testosterone may reflect ill-health, inducing an underestimation of the genetic association with 
testosterone and inflating the MR estimates24. SSIV also remediates weak-instruments bias, reducing concerns 
Genetically predicted testosterone 
(nmol/L)
Characteristic No. % Mean SD ANOVA p valuea
Age group, years 4212 0.94
 50–54 8.1 18.05 1.10
 55–59 20.2 18.01 1.22
 60–64 25.4 18.01 1.24
 65–69 24.1 18.01 1.27
 70–74 16.5 17.99 1.19
 75–79 4.2 17.95 1.28
 ≥ 80 1.5 18.15 1.52
Education 4209 0.91
 Less than primary school 2.6 18.11 1.36
 Primary school 26.9 18.01 1.22
 Junior middle school 30.0 18.01 1.19
 Senior middle school 24.2 18.01 1.23
 Junior college 8.9 17.99 1.34
 College 7.4 17.96 1.24
Smoking status 4192 0.59
 Never smoker 40.8 17.99 1.22
 Ex-smoker 27.9 18.02 1.25
 Current smoker 31.3 18.03 1.22
Use of alcohol 4212 0.49
 Never 51.8 18.02 1.25
 < 1/month 19.9 18.03 1.19
 < 1/week 4.3 18.04 1.20
 1–4/week 6.0 18.03 1.30
 5+ /week 11.9 17.90 1.19
 Ex-drinker 4.4 18.01 1.20
 Unknown 1.8 18.08 1.27
Table 2.  Genetically predicted testosterone by socio-demographic characteristics among 4,212 men (50+), 
Guangzhou Biobank Cohort Study at baseline, 2003–2008. Abbreviation: SD, standard deviation. aGenetically 
predicted testosterone was not associated with age, socioeconomic position (education) or lifestyle, including 
smoking status and use of alcohol (ANOVA p value > 0.05).
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about using multiple polymorphisms as instrument22. Any correlation of the genetic variants with unmeasured 
confounders in the sample with the phenotype is unlikely to be replicated in the sample with the outcome22. We 
also restricted the sample of young men to those with both parents and at least 3 grandparents born in Hong Kong 
or Guangdong province, to ensure genetic homogeneity, reflected by the similar allele frequencies of the genetic 
variants in the two samples18.
Although we used MR which can mimic the randomized treatment allocation in RCTs25, limitations exist. 
First, our SNP selection was limited by the lack of evidence from any genome-wide association study (GWAS) 
of testosterone in young Chinese men. Most GWAS of testosterone have been conducted in Caucasians26,27, but 
the SNPs identified have not all replicated successfully in Chinese men28. Moreover, one SNP that did replicate 
(rs2075230) in Chinese men is not suitable as a genetic instrument because of a pleiotropic association with sex 
hormone-binding globulin (SHBG)28. The GWAS are also conducted among older men, so the genetic associa-
tions might reflect accumulated age-related co-morbidities rather than testosterone29. We used a candidate gene 
approach rather than risk alleles from GWAS, given the relatively small sample of young men in Hong Kong, how-
ever, the requirement for a genetic instrument is to predict the exposure which may be based on functionality as 
well as statistical grounds30. The association of genetically predicted testosterone with lower high-density lipopro-
tein (HDL)-cholesterol18, as would be expected from meta-analysis of RCTs31, also suggests some validity of our 
genetic instrument. Second, the delayed 10-word recall test and MMSE might not be completely comprehensive. 
However, these standard tools have been validated as feasible, sensitive tools for screening mild cognitive impair-
ment in population-based research in developing countries32,33, are widely used in epidemiological studies34  
and have been previously used in this study19,35,36. Third, population stratification and canalization may affect 
MR. However, the participants were restricted to genetically homogeneous Chinese men. Moreover, it is gen-
erally assumed that a gene (and hence) a genetic score has the same effect on the phenotype across time and 
space37. No evidence suggests the association of the selected SNPs with testosterone varied by environmental 
factors. Fourth, MR is based on the assumption that the genetic instrument is associated with the exposure, is not 
associated with the outcome other than via the exposure (no pleiotropy) and no confounders of the association 
of the genetic instrument with the outcomes exist25. The selected SNPs would not be expected to affect cognitive 
function directly (pleiotropy) other than via testosterone, because the SNPs are from genes functionally relevant 
to testosterone. Some associations of genetically predicted testosterone with systemic inflammation, cardiovas-
cular disease risk factors and electrocardiographic QT interval duration have been found in our previous MR 
studies18,38,39. Cardiovascular disease is associated with cognitive decline40, as such the association with cognitive 
function might be secondary to any associations with cardiovascular disease risk factors. However, additional 
adjustment for the Framingham score (Model 5) did not change the estimates. The genetic score was not associ-
ated with estradiol (data not shown) or the confounders (as shown in Table 2). Fifth, MR requires a large sample 
size. For the 10-word recall and MMSE scores, a sample size of ~4,000 has 0.8 power to detect a relatively small 
effect size of 0.2241, according to the formula for instrumental variable analysis sample size calculation given by 
Freeman et al.41, and consistent with simulation results given by Pierce et al.42. The null associations with delayed 
10-word recall (− 0.02, 95% CI − 0.06–0.02) or MMSE (0.06, 95% CI − 0.002–0.12) might be due to lack of power. 
However, the small estimates suggest little, if any, clinical benefits, for diseases, such as Alzheimer’s disease (AD), 
given the rapid cognitive decline with disease progression. For example, delayed 10-word recall score declines 
with time at a slope of 0.12 in preclinical AD43 and MMSE score declines at the average annual rate of 3.3 in AD 
Outcome
Mean 
(SD) n Model Beta-coefficienta 95% CI P value
Delayed 10-word 5.5 4160 1 − 0.02 − 0.06–0.02 0.23
10-word recall (1.9) 4160 2 − 0.03 − 0.07–0.01 0.17
4129 3 − 0.02 − 0.06–0.02 0.27
4123 4 − 0.02 − 0.06–0.02 0.30
4093 5 − 0.02 − 0.06–0.02 0.30
3470 6 − 0.02 − 0.06–0.02 0.30
MMSE 27.5 4122 1 0.06 − 0.002–0.12 0.06
(2.7) 4122 2 0.05 − 0.007–0.11 0.08
4083 3 0.06 0.0003–0.12 0.05
4078 4 0.06 − 0.0004–0.12 0.05
4048 5 0.06 − 0.001–0.12 0.06
3443 6 0.06 − 0.01–0.13 0.10
Table 3.  Effect of genetically predicted testosterone (nmol/L) on cognitive function among men  
(50+ years), Guangzhou Biobank Cohort Study, recruitment 2003–2008 and follow up till Dec 31, 2012. 
Abbreviations: SD, standard deviation; CI, confidence interval. Model 1 showed the association of genetically 
predicted testosterone with cognitive function without any covariates; Model 2 adjusted for age; Model 3 
additionally adjusted for education, smoking, and use of alcohol; Model 4 additionally adjusted for body mass 
index (BMI); Model 5 additionally adjusted for Framingham score. Model 6 replicated the analysis in Model 1 
excluding men in another cognition project. aBeta coefficient refers to the average change in cognitive function 
(the delayed 10-word recall score and MMSE score) with each unit (nmol/L) increase in genetically predicted 
testosterone.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:21306 | DOI: 10.1038/srep21306
patients44. As such, although we cannot confirm the role of testosterone, our findings which are consistent with 
evidence from RCTs9,10, raise doubts about the observed beneficial association of testosterone with cognitive 
function4,5, with relevance to those who might be attracted globally by commercial promotion of testosterone45. 
Sixth, MR assumes linearity41, we obtained similar results assuming a log-linear association. Seventh, the result 
shows no clear association of genetically predicted testosterone with cognitive function, but might suggest a 
potential benefit for MMSE. One possible explanation is that MMSE reflects a comprehensive measure of cog-
nitive function whilst 10-word recall reflects verbal memory. The positive association for MMSE might reflect a 
potential benefit of testosterone for a specific domain of cognition, such as spatial ability, despite only a small esti-
mate for MMSE. Replication using a specific measure of spatial cognition would be desirable. Finally, correction 
for multiple testing might be appropriate when using the same study for a series of outcomes. Such correction is 
used in agnostic or exploratory studies, such as GWAS, to control for type 1 error (false positive)46. However, it 
may increase the risk of type 2 error (false negative)47,48. Given that our study aims at confirmation and our neg-
ative findings do not corroborate observed protective associations of testosterone with cognitive function among 
men, controlling for the type 2 error is important from a public health perspective.
Our study is inconsistent with some observational studies where testosterone is positively or negatively asso-
ciated with cognitive function4,5,7. However, these studies cannot distinguish whether testosterone is associated 
with cognitive function as a cause, as a symptom of disease or as a marker of an underlying process affecting 
testosterone and cognitive function. As expected, our study is consistent with some small RCTs9,10, where testos-
terone therapy had no effect on cognitive function in older men, although intervention in late adulthood may not 
be the same as lifetime intervention. The null association in our study is also consistent with observations from 
“lay epidemiology”49 where no obvious difference in overall cognitive ability exists between men and women 
despite very different levels of testosterone, although slight differences might exist in some specific domains, such 
as greater spatial ability in men50.
Our novel study provides a feasible and less biased method to test the lifetime effect of testosterone on cogni-
tive function in a short time frame without any intervention. Our study adds to the limited evidence on the role of 
testosterone in cognitive function, providing minimal support for a protective effect of endogenous testosterone. 
Given emerging concerns about the use of testosterone51, it is unclear that the potential cognitive benefit would 
outweigh the risks.
Methods
Ethics, consent and permissions. The methods were carried out in accordance with the approved guide-
lines. The protocols were approved by the University of Hong Kong-Hospital Authority Hong Kong West Cluster 
Joint Institutional Review Board. The Guangzhou Medical Ethics Committee of the Chinese Medical Association 
approved GBCS, including the use of genetic data. Written, informed consent was obtained from all participants 
prior to participation.
Study design. A separate-sample MR design was used (Supplementary Fig. S1). First, a genetic score predict-
ing serum testosterone was developed in young Chinese men from Hong Kong (sample 1), with mean age of 21.0 
years (standard deviation (SD) 1.8 years), as described previously18. Second, we applied the genetic prediction 
rule in the sample of older men from GBCS (sample 2), with the same genetic origin as sample 1, to examine the 
association of genetically predicted testosterone, rather than serum testosterone, with cognitive function among 
older Chinese men.
Sources of data. Morning blood samples were collected from students recruited from the University of Hong 
Kong, restricted to those with both parents and at least three grandparents born in Hong Kong or Guangdong 
and not taking medication affecting hormones. Testosterone was assessed by competitive immunoassay on Vitros 
3600 immunodiagnostic system (Ortho Clinical Diagnostics Inc, USA) with a detection limit of 0.17 nmol/L. The 
intra- and inter-assay coefficients of variation were 4.9% and 5.7% at 4.4 nmol/L, 3.2% and 3.9% at 16.3 nmol/L, 
and 1.8% and 3.0% at 37.5 nmol/L, respectively. DNA was extracted and analyzed at the Centre for Genomic 
Sciences of the University of Hong Kong for selected SNPs from ESR1 (rs722208 and rs2175898), CYP19A1 
(rs10046 and rs1008805) and ESR2 (rs1256030 and rs1256031) using a Mass ARRAY system (Sequenom, San 
Diego, California), for establishing the genetic prediction rule, following the flow chart (shown in Supplementary 
Fig. S2). A self-administered questionnaire was used to collect socioeconomic position and health status.
GBCS is an ongoing collaboration of Guangzhou Number 12 Hospital, the Universities of Hong Kong and 
Birmingham, UK52. Recruitment was in 3 phases. All participants were permanent residents of Guangzhou aged 
50+ years and members of the “The Guangzhou Health and Happiness Association for the Respectable Elders” 
(GHHARE), a community social and welfare association unofficially aligned with the municipal government. 
Membership of GHHARE is open to older people for a monthly fee of 4 Yuan (50 US cents). About 7% of perma-
nent Guangzhou residents aged 50+ years are members of GHHARE, of whom 11% (~10,000) enrolled for each 
of phases one, two and three. Inclusion criteria were that they were capable of consenting, ambulatory, and not 
receiving treatment modalities which if omitted may result in immediate life threatening risk, such as chemother-
apy or radiotherapy for cancer, or dialysis for renal failure. Fasting blood samples were collected at recruitment 
in phase 3 and at follow-up for participants recruited in other phases. Samples were stored, as whole blood or as 
buffy coat and sera, at − 80 °C for all apart from a subset of phase 3 participants whose DNA was extracted from 
fresh blood and stored at − 80 °C. Selected SNPs were analyzed by a commercial company (Beijing CapitalBio 
Corporation) in Beijing using a Mass ARRAY system (Sequenom, San Diego, California).
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Cognitive function test. Cognitive function was assessed from a test battery developed for the Consortium 
to Establish a Registry for Alzheimer’s Disease (CERAD)53. In all 3 phases at baseline and follow-up we used the 
test of new learning ability (10-word list learning task). Four words (“arm”, “letter”, “ticket” and “grass”) were taken 
from the original CERAD English language test33. “Pole”, “shore”, “cabin” and “engine” were replaced with “cor-
ner”, “stone”, “book” and “stick” as in the adapted CERAD 10-word list learning task33. “Butter” and “queen” were 
replaced with “soy sauce” and “chairman” to be culturally appropriate. During the learning phase the 10-word list 
was read to the participants who were then asked to recall immediately. This was repeated 3 times giving imme-
diate recall. After a 5-minute period of distraction, during which the interview was continued, the participants 
were asked to recall as many of the 10 words as possible. Delayed recall score is generally more predictive than 
immediate recall score and less affected by education33, so delayed rather than immediate recall score was used. 
The adapted Consortium 10-word list learning task has been validated as a culturally and educationally sensitive 
tool for identifying dementia in population-based research in developing countries33 and reported previously in 
this study19,35,36.
MMSE was used in phase 3 at baseline and follow-up for all phases. MMSE is the most commonly adminis-
tered psychometric screening assessment of cognition54. MMSE is a general cognition test covering orientation, 
attention, memory, recall and language55, widely used as a relatively sensitive marker of cognitive impair-
ment54,56,57. Three of 11 tasks in the original MMSE were amended to be more culturally appropriate. Orientation 
in place was adapted according to the geographical divisions of China and the screening setting to “country”, 
“province”, “city”, “hospital” and “floor”. In the 3-word registration and recall “table” and “penny” were replaced 
with “newspaper” and “train” to ensure all 3 words were frequently used 2-character Chinese words. The modified 
MMSE has the same scale as the original MMSE58 hence, the psychometric properties of the measures should be 
similar. The modified MMSE has been previously reported19,35,36.
Exposure. The exposure was genetically predicted testosterone, estimated as the anti-log of predicted log 
testosterone from the genetic score. Serum testosterone was not measured in older men in GBCS. Testosterone, 
instead of log testosterone, was used for ease of interpretation as it gave the same pattern of results.
Outcomes. The primary outcomes were delayed 10-word recall score (out of 10) and MMSE score (out of 30). 
The delayed 10-word recall score was normally distributed. The MMSE score was skewed, but the sample size 
is large59. Preliminary analysis showed similar results using logged MMSE, so the results in natural units are 
presented. Higher scores indicate better performance.
Statistical analysis. In the young men, after testing for Hardy-Weinberg equilibrium and linkage disequi-
librium, rs2175898 was dropped because it deviated from Hardy-Weinberg equilibrium, rs1256030 was dropped 
because it was in linkage disequilibrium with rs125603118. Stepwise linear regression with all the remaining 
candidate SNPs (rs722208, rs10046, rs1008805, rs1256031) was used to find a parsimonious set of SNPs which 
best predicted log testosterone, as described previously18. The F-statistic, calculated from the regression of log 
testosterone on genetically predicted log testosterone, was obtained; an F-statistic >10 suggests a reliable genetic 
instrument60.
In the older men from GBCS, a test for trend was used to compare genetically predicted testosterone by 
key characteristics. We used generalized estimating equation models to estimate the relation of genetically pre-
dicted testosterone with cognition using data from both baseline and follow-up to take into account any corre-
lation between two measurements for the same man. Although the association should not be confounded by 
socioeconomic position, lifestyle, or health attributes, covariates were included to achieve more precise esti-
mates61. Model 1 had no covariates. Model 2 adjusted for age. Model 3 additionally adjusted for education, smok-
ing and use of alcohol. Model 4 additionally adjusted for body mass index (BMI). Model 5 additionally adjusted 
for the Framingham score, because it is associated with cognitive decline62. We assessed whether the association 
of genetically predicted testosterone with cognition varied with age4, from the relevant interaction term. GBCS 
is a large cohort for answering many research questions; 690 men with all 3 SNPs for genetically predicted tes-
tosterone had SNP testing for another project on cognitive decline20. In model 6, we repeated the analysis with 
these men excluded. The power calculation was conducted using the formula for an instrumental variable anal-
ysis sample size given by Freeman et al.41, the sample size for such studies is approximately the usual sample size 
for exposure on outcome divided by the R2 between instrument and exposure. We also compared the power 
calculation with the simulation results of Pierce et al.42. All statistical analyses were conducted using Stata 10.1 
(StataCorp LP, College Station, Texas).
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